STOCKWATCH
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate GovernanceApr 24, 2026, 04:46 PM

Arcellx Files Amended 10-K, Confirms Large Filer Status; $3.2B Market Cap

AI Summary

Arcellx, Inc. filed an amended Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025. The company confirmed its status as a well-known seasoned issuer and a large accelerated filer, indicating its compliance with SEC reporting requirements. Additionally, the filing noted an aggregate market value of approximately $3.2 billion for its common stock held by non-affiliates as of June 30, 2025.

Key Highlights

  • Filed Form 10-K/A (Amendment No. 1) for the fiscal year ended December 31, 2025.
  • Confirmed status as a well-known seasoned issuer.
  • Designated as a large accelerated filer.
  • Non-affiliate common stock market value was approximately $3.2 billion as of June 30, 2025.
View SEC Filing